NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 8.67% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.78% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 6.75% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.72% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.55% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.51% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.02% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 4.01% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.84% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.71% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.55% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.15% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.09% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.85% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.44% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.37% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.36% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.91% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |